Patient, Family, Caregiver Symposium 1/28 - Sign Up Today!
Dr. Blount, Ph. D. CSO at Rebiotix, Inc., a Ferring Company, is a seasoned director of collaborative research programs in biotech, pharma, clinical, and academic research settings .
Symposium Chair and Guest Speaker
Dr. Khanna, M.B.B.S., M.S., is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. His research and clinical interests include Epidemiology, Outcomes, and Emerging Therapeutics for Clostridium difficile infection, an arena in which he has had numerous publications and presentations. He is directing the C. difficile Clinic, Fecal Microbiota Transplantation program, and C. difficile related Clinical Trials at Mayo Clinic, Rochester, MN.
Paul Plumb joined the Rebiotix clinical team in 2015, and currently serves as the Head of Clinical Operations .
He has over 30 years of medical technology and healthcare delivery experience, focused on minimally-invasive techniques, investigational devices, and most recently new drug development in the microbiome field.
Maureen Spencer has been an Infection Preventionist for over 40 years and is board certified in infection control (CIC). As one of the early pioneers in infection control, she was awarded the APIC National Carole DeMille Award in 1990 and was selected as one of the APIC Heroes of Infection Prevention in 2007 for her work in establishing an MRSA and Staph aureus Elimination Program at New England Baptist Hospital, an Orthopedic Center of Excellence in Boston.
C. diff. Survivor
Alba Muhlfeld joins us in sharing her C. difficile infection journey and key points on healthcare advocacy.
Dr. Chopra, MD,MPH,FACP,FIDSA,FSHEA, an infectious disease specialist, Teena Chopra is a professor of internal medicine, infectious diseases, for the Wayne State University School of Medicine, as well as the corporate medical director of infection prevention and hospital epidemiology at the Detroit Medical Center.
Kelly Moushey, CEO of
St. Charles Clinical Research with an extensive background in clinical research, Kelly has a passion engaging directly with the trial participants as they are screened for eligibility, develop and implement recruitment strategies, and liaise with all teams throughout the trials.
Program Key Points - Overview